๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Effects of somatostatin added to insulin in a glucose-controlled insulin infusion system

โœ Scribed by J. L. Selam; D. Chenon; T. C. Pham; J. P. Gagnol; C. Sany; N. Thomas; G. Gravagne; A. Orsetti; J. Mirouze


Publisher
Springer
Year
1981
Tongue
English
Weight
369 KB
Volume
21
Category
Article
ISSN
0012-186X

No coin nor oath required. For personal study only.

โœฆ Synopsis


Five insulin treated diabetics were studied on three consecutive days. Overnight variable intravenous insulin infusions were used before each study to maintain normoglycaemia and to calculate the optimal basal insulin infusion rate (1.1 +/- 0.1 U/h) which ws then kept constant throughout the study day. A standard 400 kCal breakfast with 25 g xylose was given at 0800 h. When the blood glucose rose above 4.1 mmol/l, an external artificial pancreas was used to infuse either extra insulin (day INS) or somatostatin for either 3h (day som) or the entire 8h experimental period (day SOM). Peak post-prandial blood glucose values were similar on all three days. The blood glucose rebounded after the cessation of the somatostatin infusion on day som. Post-prandial blood xylose peaks were lowered by somatostatin on both days but rebounded after the cessation of the somatostatin infusion on day som. The area under the plasma and urinary xylose curves was lowered by somatostatin only on day SOM. Growth hormone and glucagon levels were not statistically different on all 3 days. Thus somatostatin, when added to an optimal insulin infusion, minimised the insulin requirements by slowing intestinal absorption, but led to rebound hyperglycaemia if not feed-back controlled.


๐Ÿ“œ SIMILAR VOLUMES


Allergy reactions to insulin: effects of
โœ R. P. Radermecker; A. J. Scheen ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 122 KB

## Abstract The purification of animal insulin preparations and the use of human recombinant insulin have markedly reduced the incidence but not completely suppressed the occurrence of insulin allergy manifestations. Advances in technologies concerning the mode of delivery of insulin, i.e. continuo

A comparison of the artificial pancreas
โœ M. Ponchner; R. J. Heine; A. Pernet; I. Manning; A. J. Francis; D. Cook; H. ร˜rsk ๐Ÿ“‚ Article ๐Ÿ“… 1984 ๐Ÿ› Springer ๐ŸŒ English โš– 586 KB

Two main methods are available for assessing insulin sensitivity with the hyperinsulinaemic euglycaemic clamp technique: one employs a glucose-controlled insulin infusion system (the Biostator) with automatic feedback control; the second depends on frequent glucose measurement and the use of an algo